Company news
Infant Bacterial Therapeutics AB news in 2025
Infant Bacterial Therapeutics AB's news releases, calls and decks from 2025, newest first.
Infant Bacterial Therapeutics Secures Partnership For Production Of Drug Product
December 12, 2025
Infant Bacterial Therapeutics Secures Partnership For Production Of Drug Substance
November 20, 2025
Infant Bacterial Therapeutics Q3 Operating Loss SEK 48.5 Mln
November 13, 2025
Infant Bacterial Therapeutics AB: Quarterly Trading Report 2025 Q3
October 3, 2025
IBT_B: FDA review of IBP-9414 progresses as losses narrow and launch preparations intensify
August 20, 2025
IBT_B: FDA Breakthrough Therapy Designation for IBP-9414 accelerates IBT's market path
May 7, 2025
IBT_B: IBP-9414's Phase 3 trial showed 27% lower mortality; BLA submission planned for 2025
February 13, 2025